17.87
Schlusskurs vom Vortag:
$17.36
Offen:
$17.76
24-Stunden-Volumen:
479.55K
Relative Volume:
0.72
Marktkapitalisierung:
$915.24M
Einnahmen:
$379.81M
Nettoeinkommen (Verlust:
$-21.35M
KGV:
-45.32
EPS:
-0.3943
Netto-Cashflow:
$35.44M
1W Leistung:
-1.16%
1M Leistung:
-4.74%
6M Leistung:
+19.13%
1J Leistung:
+0.96%
Caredx Inc Stock (CDNA) Company Profile
Firmenname
Caredx Inc
Sektor
Branche
Telefon
415-287-2300
Adresse
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CDNA
Caredx Inc
|
17.87 | 889.12M | 379.81M | -21.35M | 35.44M | -0.3943 |
|
TMO
Thermo Fisher Scientific Inc
|
494.54 | 183.71B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.79 | 135.02B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
564.66 | 44.85B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
114.54 | 32.37B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
299.89 | 29.42B | 3.17B | 642.63M | 516.49M | 10.77 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Herabstufung | Craig Hallum | Buy → Hold |
| 2025-08-26 | Eingeleitet | William Blair | Mkt Perform |
| 2025-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
| 2024-08-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-05-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Hochstufung | Craig Hallum | Hold → Buy |
| 2023-11-09 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-03-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-03-03 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2021-07-20 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-26 | Eingeleitet | BTIG Research | Buy |
| 2020-06-19 | Bestätigt | H.C. Wainwright | Buy |
| 2019-10-01 | Fortgesetzt | Craig Hallum | Buy |
| 2019-05-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Eingeleitet | Jefferies | Buy |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Neutral |
| 2017-11-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-14 | Bestätigt | Mizuho | Buy |
| 2015-09-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Eingeleitet | Craig Hallum | Buy |
| 2015-03-18 | Bestätigt | Mizuho | Buy |
Alle ansehen
Caredx Inc Aktie (CDNA) Neueste Nachrichten
CareDx (CDNA) director exercises 26,500 options, now holds 183,961 shares - Stock Titan
CareDx, Inc. (NASDAQ:CDNA) Receives Consensus Recommendation of "Hold" from Analysts - marketbeat.com
Support Test: Can CareDx Inc maintain sales growthRecession Risk & AI Powered Market Entry Ideas - baoquankhu1.vn
CareDx Inc (CDNA) Stock Price Quote Today & Current Price Chart - Capital.com
CareDx Inc (CDNA) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Volatility Watch: Can CareDx Inc stock outperform in a bear market2026 Levels & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
CareDx, Inc. (CDNA) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
CDNA (CareDx) Shiller PE Ratio : (As of Mar. 27, 2026) - GuruFocus
Setup Watch: How liquid is CareDx Inc stockLong Setup & Step-by-Step Swing Trade Plans - baoquankhu1.vn
[SCHEDULE 13G/A] CareDx, Inc. Amended Passive Investment Disclosure - Stock Titan
Exploring 3 High Growth Tech Stocks in the US Market - simplywall.st
Published on: 2026-03-26 22:03:28 - baoquankhu1.vn
Street Watch: What is the cash position of CareDx Inc2026 Chart Watch & Real-Time Stock Movement Alerts - baoquankhu1.vn
CareDx (NASDAQ:CDNA) Share Price Crosses Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
CareDx, Inc. (CDNA) Stock Price Prediction for 2026, 2030-2040 - Traders Union
(CDNA) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Live CareDx, Inc. (CDNA) Technical Analysis - Traders Union
CareDx, Inc. (CDNA) Stock Price Today | Live Chart & News - Traders Union
CareDx (CDNA) Launches AI-based Platform VANTx - Insider Monkey
10 Best Diagnostics and Research Stocks to Buy According to Analysts - Insider Monkey
If You Invested $1,000 in Caredx (CDNA) - Stock Titan
CareDx (CDNA) Q4 earnings miss estimates - MSN
CDNA,SPOK Options - Finviz
Stock Analysis: Should you avoid CareDx Inc stock right now2026 Volatility Report & Growth Focused Stock Reports - baoquankhu1.vn
Trend Review: Should you avoid CareDx Inc stock right now2026 Bull vs Bear & Proven Capital Preservation Methods - baoquankhu1.vn
CareDx introduces VANTx AI platform for complex transplant datasets - MSN
Fred Alger Management LLC Sells 304,736 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx rebounds as draft LCD suggests no change in coverage - MSN
How The CareDx (CDNA) Story Is Shifting With CMS LCD Uncertainty And New Guidance - Yahoo Finance
Bamco Inc. NY Has $45.88 Million Stake in CareDx, Inc. $CDNA - MarketBeat
Braidwell LP Makes New Investment in CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. $CDNA Shares Purchased by ArrowMark Colorado Holdings LLC - MarketBeat
Prosight Management LP Grows Stock Holdings in CareDx, Inc. $CDNA - MarketBeat
Portolan Capital Management LLC Grows Stake in CareDx, Inc. $CDNA - MarketBeat
(CDNA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
CareDx raises 2025 revenue guidance to $372M–$376M with robust RCM gains and new product launches - MSN
CareDx Launches VANTx AI Solution for Advanced Transplant Data Analysis - Bitget
CareDx Introduces VANTx AI Platform for Complex Transplant Datasets - Zacks Investment Research
CareDx reports positive data for AlloHeme in AML and MDS post HCT - MSN
CareDx wins preliminary court approval for derivative settlement - MSN
CDNA PE Ratio & Valuation, Is CDNA Overvalued - Intellectia AI
CareDx Details Transplant+ Roadmap, AlloHeme Timeline, and 2026 Outlook at Raymond James Conference - MarketBeat
Paragon Associates & Paragon Associates II Joint Venture Buys 205,597 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. (NASDAQ:CDNA) Given Consensus Rating of "Hold" by Analysts - MarketBeat
CareDx Q4 2025 earnings preview - msn.com
CareDx launches AI platform for transplant research By Investing.com - Investing.com Australia
CareDx Earnings Call Highlights Growth Amid Reimbursement Risks - TipRanks
CareDx launches AI platform for transplant research - Investing.com
CareDx (CDNA) Introduces VANTx: A Revolutionary AI Data Platform for Transplants - GuruFocus
CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets - Business Wire
Royce & Associates LP Has $5.88 Million Stake in CareDx, Inc. $CDNA - MarketBeat
Finanzdaten der Caredx Inc-Aktie (CDNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):